Search details
1.
Bat pluripotent stem cells reveal unusual entanglement between host and viruses.
Cell
; 186(5): 957-974.e28, 2023 03 02.
Article
in English
| MEDLINE | ID: mdl-36812912
2.
The Global Phosphorylation Landscape of SARS-CoV-2 Infection.
Cell
; 182(3): 685-712.e19, 2020 08 06.
Article
in English
| MEDLINE | ID: mdl-32645325
3.
Transcription Elongation Can Affect Genome 3D Structure.
Cell
; 174(6): 1522-1536.e22, 2018 09 06.
Article
in English
| MEDLINE | ID: mdl-30146161
4.
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.
Nature
; 583(7816): 459-468, 2020 07.
Article
in English
| MEDLINE | ID: mdl-32353859
5.
Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing.
Nature
; 586(7827): 113-119, 2020 10.
Article
in English
| MEDLINE | ID: mdl-32707573
6.
Structures of SARS-CoV-2 N7-methyltransferase with DOT1L and PRMT7 inhibitors provide a platform for new antivirals.
PLoS Pathog
; 19(7): e1011546, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37523415
7.
Functional Effects of Cardiomyocyte Injury in COVID-19.
J Virol
; 96(2): e0106321, 2022 01 26.
Article
in English
| MEDLINE | ID: mdl-34669512
8.
SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling.
Proc Natl Acad Sci U S A
; 117(45): 28344-28354, 2020 11 10.
Article
in English
| MEDLINE | ID: mdl-33097660
9.
The IRE1α-XBP1 arm of the unfolded protein response is a host factor activated in SARS-CoV-2 infection.
Biochim Biophys Acta Mol Basis Dis
; 1870(5): 167193, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38648902
10.
Pharmacological disruption of mSWI/SNF complex activity restricts SARS-CoV-2 infection.
Nat Genet
; 55(3): 471-483, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36894709
11.
SARS-CoV-2 Inhibitors Identified by Phenotypic Analysis of a Collection of Viral RNA-Binding Molecules.
Pharmaceuticals (Basel)
; 15(12)2022 Nov 22.
Article
in English
| MEDLINE | ID: mdl-36558898
12.
Common and species-specific molecular signatures, networks, and regulators of influenza virus infection in mice, ferrets, and humans.
Sci Adv
; 8(40): eabm5859, 2022 10 07.
Article
in English
| MEDLINE | ID: mdl-36197970
13.
Sec61 Inhibitor Apratoxin S4 Potently Inhibits SARS-CoV-2 and Exhibits Broad-Spectrum Antiviral Activity.
ACS Infect Dis
; 8(7): 1265-1279, 2022 07 08.
Article
in English
| MEDLINE | ID: mdl-35766385
14.
The oral drug nitazoxanide restricts SARS-CoV-2 infection and attenuates disease pathogenesis in Syrian hamsters.
bioRxiv
; 2022 Feb 09.
Article
in English
| MEDLINE | ID: mdl-35169796
15.
Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19.
Life Sci Alliance
; 5(4)2022 04.
Article
in English
| MEDLINE | ID: mdl-35012962
16.
Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19.
Sci Rep
; 11(1): 12310, 2021 06 10.
Article
in English
| MEDLINE | ID: mdl-34112877
17.
Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19.
Res Sq
; 2021 Mar 30.
Article
in English
| MEDLINE | ID: mdl-33821262
18.
Phospholipidosis is a shared mechanism underlying the in vitro antiviral activity of many repurposed drugs against SARS-CoV-2.
bioRxiv
; 2021 Mar 24.
Article
in English
| MEDLINE | ID: mdl-33791693
19.
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A.
Science
; 371(6532): 926-931, 2021 02 26.
Article
in English
| MEDLINE | ID: mdl-33495306
20.
Host-directed therapies against early-lineage SARS-CoV-2 retain efficacy against B.1.1.7 variant.
bioRxiv
; 2021 Feb 04.
Article
in English
| MEDLINE | ID: mdl-33501437